# ZNF623

## Overview
ZNF623 is a gene that encodes the zinc finger protein 623, which is categorized as a zinc finger protein due to its characteristic structural motif that facilitates binding to DNA. This protein plays a pivotal role in transcriptional regulation, influencing gene expression and participating in essential cellular processes such as differentiation, proliferation, and apoptosis. ZNF623 is predominantly localized in the nucleus, where it engages in interactions that modulate gene activity and RNA processing. While the precise functions of ZNF623 in normal physiology are not completely understood, its involvement in RNA binding and processing suggests a significant role in maintaining cellular homeostasis. Additionally, ZNF623 has been implicated in cancer research, particularly as a potential biomarker for hepatocellular carcinoma, highlighting its relevance in clinical contexts (Xu2018Identification).

## Function
ZNF623, a zinc finger protein, is primarily involved in transcriptional regulation within healthy human cells. It is part of a group of proteins that bind to DNA and influence gene expression, playing a crucial role in various cellular processes such as differentiation, proliferation, and apoptosis. ZNF623 is notably active in the nucleus, where it interacts with other molecular components to modulate gene activity (Xu2018Identification).

The protein is associated with molecular functions such as RNA binding, nucleic acid binding, and poly-A-RNA binding. It is localized in cellular components like the nucleus, nuclear lumen, and nuclear part, indicating its involvement in RNA processing, non-coding RNA processing, and RNA phosphodiester bond hydrolysis (Xu2018Identification). These activities suggest that ZNF623 may play a role in maintaining the integrity of RNA molecules and regulating their function within the cell.

While the specific functions of ZNF623 in healthy human cells are not fully detailed, its expression and activity in the nucleus imply a significant role in the regulation of gene expression and cellular homeostasis, potentially impacting organismal outcomes related to cell growth and development (Xu2018Identification).

## Clinical Significance
ZNF623 has been identified as a potential biomarker in hepatocellular carcinoma (HCC), particularly in relation to the Barcelona Clinic Liver Cancer (BCLC) staging and overall survival of patients. Research using Weighted Gene Co-expression Network Analysis (WGCNA) found that ZNF623 is part of a gene module strongly correlated with BCLC staging and patient survival. Functional annotation of the hub genes, including ZNF623, indicated their involvement in RNA processing and binding, suggesting a role in tumor progression (Xu2018Identification).

In liver cancer, ZNF623 was found to have significantly higher expression levels in primary tumor tissues compared to normal liver tissues, indicating its potential clinical significance in tumor staging and prognosis (Xu2018Identification). Although the specific functions of ZNF623 in cancer remain unclear, its correlation with liver cancer suggests it could serve as a prognostic marker, warranting further investigation (Xu2018Identification).

In gastric cancer, ZNF623 is a validated target of miR-627-5p, and alterations in miRNA-mRNA interactions due to polymorphisms may affect its expression, although the clinical significance in this context is not fully detailed (Raad2020Association).

## Interactions
ZNF623, a zinc finger protein, has been identified as a putative binding partner of the MxA protein, which is encoded by the MX1 gene. This interaction was discovered through a yeast two-hybrid screen aimed at identifying new binding partners of MxA. The study grouped the identified ligands into biological processes such as cell cycle control, transcription regulation, apoptosis, and DNA damage response. ZNF623 was specifically noted as a zinc finger protein among these ligands, although the excerpt does not provide detailed information about the nature of its interaction with MxA or other proteins and nucleic acids (BrantisdeCarvalho2015MxA).

In the context of cancer research, ZNF623 has been mentioned as a gene with unclear functions but with potential implications in liver cancers, suggesting it could serve as a prognostic marker for hepatocellular carcinoma (HCC). However, specific interactions of ZNF623 with proteins or nucleic acids in this context are not detailed (Xu2018Identification).

Overall, while ZNF623 is implicated in interactions with MxA and potentially in cancer prognosis, detailed mechanisms of its interactions with proteins or nucleic acids remain to be elucidated.


## References


[1. (Xu2018Identification) Wei Xu, Quan Rao, Yongbo An, Mengyi Li, and Zhongtao Zhang. Identification of biomarkers for barcelona clinic liver cancer staging and overall survival of patients with hepatocellular carcinoma. PLOS ONE, 13(8):e0202763, August 2018. URL: http://dx.doi.org/10.1371/journal.pone.0202763, doi:10.1371/journal.pone.0202763. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0202763)

[2. (BrantisdeCarvalho2015MxA) Carlos Eduardo Brantis-de-Carvalho, Ghizlane Maarifi, Paulo Eduardo Gonçalves Boldrin, Cleslei Fernando Zanelli, Sébastien Nisole, Mounira K. Chelbi-Alix, and Sandro Roberto Valentini. Mxa interacts with and is modified by the sumoylation machinery. Experimental Cell Research, 330(1):151–163, January 2015. URL: http://dx.doi.org/10.1016/j.yexcr.2014.10.020, doi:10.1016/j.yexcr.2014.10.020. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2014.10.020)

[3. (Raad2020Association) M Raad, Z Salehi, M Habibzaadeh Baalsini, F Mashayekhi, and H Saeidi Saedi. Association of rs2620381 polymorphism in mir-627 and gastric cancer. British Journal of Biomedical Science, 77(2):76–80, January 2020. URL: http://dx.doi.org/10.1080/09674845.2019.1692762, doi:10.1080/09674845.2019.1692762. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/09674845.2019.1692762)